|
|
Article: Drug-eluting stents beat CABG in kidney patients.(Nephrology)(coronary artery bypass grafting)(Clinical report)
- Article from:
- Internal Medicine News
- Article date:
- January 15, 2008
- Author:
CopyrightCOPYRIGHT 2008 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN FRANCISCO -- Patients with chronic kidney disease apparently do better with percutaneous coronary intervention with drug-eluting stents than with bare-metal stents or with coronary artery bypass grafts, according to a study presented by Dr. Charles A. Herzog at the annual meeting of the American Society of Nephrology.
But the study should be interpreted with caution because it was retrospective, relied on administrative data, and might have been subject to selection bias, said Dr. Herzog, of the University of Minnesota, Minneapolis.
"The message is that drug-eluting stents are definitely not worse than surgery" for patients with chronic kidney ...